Skip to main content
. 2017 Feb 25;8(5):793–800. doi: 10.7150/jca.17766

Figure 2.

Figure 2

Survival analysis in the whole cohort of 53 patients with ENKTL. Patients with positive expression percentage >20% for MYC (A, B) or >70% for BCL2 (C, D) have significantly inferior PFS and OS; According to the DHS, patients could be divided into three significantly different risk groups for PFS and OS (E, F).